Artem Kaplan is a Neurology physician. OpenAlex indexes 8 publications with 892 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
710 W 168th St
New York, NY 100323726
Telephone
646-426-3876Provider last certified this registry record 21 Nov 2022.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202544 payments
- PFIZER INC.Program year202515 payments
- Teva Pharmaceuticals USA, Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
99.5%Neuromuscular Blocker99.5%Onabotulinumtoxina100%Part B, office-administered≥119 patientsNervous system
0.4%Gabapentinoids0.1%Gabapentin100%Part D≥42 patientsSSRI0.1%Escitalopram Oxalate67%Trazodone Hcl20%Sertraline Hcl12%Part D<11 patients+ 7 more classes in this area
Dermatology
0%Corticosteroid0%Methylprednisolone acetate100%Part B, office-administered≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2011 per NIH RePORTER. The latest:
- Mechanisms underlying development and resistance of ALS of specific motor pools
Columbia University Health Sciences
FY2011$46,800F30NS065635 - Mechanisms underlying development and resistance of ALS of specific motor pools
Columbia University Health Sciences
FY2010$46,380F30NS065635 - Mechanisms underlying development and resistance of ALS of specific motor pools
Columbia University Health Sciences
FY2009$46,176F30NS065635
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”